389030 — Geninus Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual income statement for Geninus, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	—	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	8,134	10,083	6,967	6,455	10,483
Cost of Revenue
Gross Profit	1,026	849	83.2	81.1	173
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	15,756	19,766	17,063	18,745	22,155
Operating Profit	-7,621	-9,683	-10,096	-12,289	-11,671
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-9,019	-9,385	-9,684	-12,273	-17,373
Provision for Income Taxes
Net Income After Taxes	-9,019	-9,385	-9,684	-12,273	-17,373
Net Income Before Extraordinary Items
Net Income	-9,019	-9,385	-9,684	-12,273	-17,373
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-9,019	-9,385	-9,684	-12,273	-17,373
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-277	-287	-292	-367	-520
Dividends per Share